Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension

Inclusion Criteria:

• Diagnosis of either open-angle glaucoma or ocular hypertension in each eye thatrequire IOP lowering treatment.
• In the investigator's opinion, patient's IOP is not adequately managed with topicalmedication for reasons other than medication efficacy (eg, due to intolerance ornonadherence).
• In the investigator's opinion, both eyes can be treated adequately with topicalprostamide, prostaglandin, or prostaglandin analog eye drops as the sole therapy ifmedication was taken as directed, or with SLT monotherapy.

Exclusion Criteria:

• History of previous laser trabeculoplasty
• History or evidence of complicated cataract surgery: eg, surgery resulting incomplicated lens placement (such as anterior chamber intraocular lens implant [IOL],sulcus IOL, aphakia, etc) or intraoperative complications (such as a posteriorcapsular tear [with or without vitreous loss], substantial iris trauma, etc) orhistory of phakic IOL insertion for refractive error correction
• Intraocular surgery (including cataract surgery) and/or any ocular laser surgerywithin the 6 months prior to treatment
• Previous use of commercially available Bimatoprost SR; concurrent enrollment inanother Allergan Bimatoprost SR study; or previous enrollment in which an implant wasreceived.